Ryan J. Watts
2018
In 2018, Ryan J. Watts earned a total compensation of $6M as President and Chief Executive Officer at Denali Therapeutics, a 338% increase compared to previous year.
Compensation breakdown
| Bonus | $524,563 |
|---|---|
| Option Awards | $4,914,360 |
| Salary | $545,000 |
| Total | $5,986,614 |
Watts received $4.9M in option awards, accounting for 82% of the total pay in 2018.
Watts also received $524.6K in bonus and $545K in salary.
Rankings
In 2018, Ryan J. Watts' compensation ranked 1,574th out of 14,244 executives tracked by ExecPay. In other words, Watts earned more than 88.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,574 out of 14,244 | 89th |
Division Manufacturing | 553 out of 5,765 | 90th |
Major group Chemicals And Allied Products | 172 out of 2,128 | 92nd |
Industry group Drugs | 135 out of 1,817 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 33 out of 339 | 90th |
Source: SEC filing on April 18, 2019.
Watts' colleagues
We found three more compensation records of executives who worked with Ryan J. Watts at Denali Therapeutics in 2018.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019